Business

NuGen M.D. Receives Additional Health Canada Approval for Insulin Specific Needle-Free Injection System

TORONTO, ON / ACCESSWIRE / July 21, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD) ("NuGen'...

articleNugen Medical Devices IncJuly 21, 20224/company/nugen-medical-devices-inc/news/nugen-md-receives-additional-health-canada-approval-for-insulin-specific-needle-free-injection-system
NuGen M.D. Receives Additional Health Canada Approval for Insulin Specific Needle-Free Injection System

About this update from Nugen Medical Devices Inc

[{"type":"text","content":"NuGen M.D. Receives Additional Health Canada Approval for Insulin Specific Needle-Free Injection SystemTORONTO, ON / ACCESSWIRE / July 21, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD) (\"NuGen'' or the \"Company\"), a leader in needle-free drug delivery, is pleased to announce that its needle-free injection system and accessories, also known as InsuJet™, has been approved by Health Canada specifically for the needle-free delivery of insulin.While NuGen previously announced on December 9, 2021, that its needle-free injection system had received general use approval from Health Canada, the insulin specific approval is the first ever* insulin specific needle-free system approved by Health Canada to sell into the healthcare system and its end users. Additionally, this approval may also aid in the process of obtaining coverage for the system by certain health care insurance providers in Canada.\"This is another important milestone in paving the way for diabetics in Canada to be able to easily acquire and use our needle-free injection device to deliver pain-free and fear-free insulin,\" said Michael Wright, CEO of NuGen. \"Our device was specifically developed for the benefit of patients that need to self-inject themselves in order to manage their chronic illnesses and offers variable dosing of insulin units which is required for diabetics that must self-inject multiple times throughout the day. This additional Health Canada approval brings more clarity to the intended use of the device and will further support our marketing initiatives to the diabetic community. Our goal is to have our technologies accessible not only to the diabetic community, but to give all patients that are currently burdened with injecting themselves with a needle the option of using a needle-free device.\"Currently, in Canada alone, there are more than 5.7 million people living with diabetes, representing 14% of the population according to Diabetes Canada.[1]Diabetes can also cause other health complications and disabilities, and is the leading cause of blindness, end stage renal disease (ESRD), and non-traumatic amputation in Canadian adults.[2] According to the International Diabetes Federation (IDF), one person dies due to complications related to diabetes every 5 seconds, making it one of the leading causes of death worldwide.[3]In both type 1 and t...

More updates from Nugen Medical Devices Inc